每经记者:陈星每经编辑:梁枭3月25日收盘后,药明生物(02269.HK,股价27.45港元,市值1127.4亿港元)发布年度业绩公告。数据显示,公司2024年实现收入186.754亿元,同比增长9.6%;全年纯利为39.45亿元,同比增长10.5%;公司拥有人应占纯利为33.56亿元,同比下降1.3%。从财务数据看,这是药明生物连续第二年出现利润收缩。但在26日进行的业绩说明会上,药明生物方面...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.